OraSure Technologies Stock Forecast, Price & News

OraSure Technologies (NASDAQ:OSUR) Frequently Asked Questions

Is OraSure Technologies a buy right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for OraSure Technologies in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" OraSure Technologies stock.
View analyst ratings for OraSure Technologies or view top-rated stocks.

How has OraSure Technologies' stock price been impacted by Coronavirus (COVID-19)?

OraSure Technologies' stock was trading at $5.90 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, OSUR shares have increased by 61.5% and is now trading at $9.53.
View which stocks have been most impacted by COVID-19.

When is OraSure Technologies' next earnings date?

OraSure Technologies is scheduled to release its next quarterly earnings announcement on Monday, March 7th 2022.
View our earnings forecast for OraSure Technologies.

How were OraSure Technologies' earnings last quarter?

OraSure Technologies, Inc. (NASDAQ:OSUR) announced its quarterly earnings results on Wednesday, November, 3rd. The medical instruments supplier reported ($0.21) EPS for the quarter, missing analysts' consensus estimates of ($0.05) by $0.16. The medical instruments supplier had revenue of $53.92 million for the quarter, compared to analyst estimates of $47.54 million. OraSure Technologies had a negative trailing twelve-month return on equity of 2.70% and a negative net margin of 4.61%. During the same quarter last year, the firm posted $0.01 earnings per share.
View OraSure Technologies' earnings history.

What guidance has OraSure Technologies issued on next quarter's earnings?

OraSure Technologies issued an update on its FY 2021 earnings guidance on Wednesday, November, 17th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $230 million-$233 million, compared to the consensus revenue estimate of $235.90 million.

What price target have analysts set for OSUR?

3 equities research analysts have issued 12 month target prices for OraSure Technologies' shares. Their forecasts range from $12.50 to $20.00. On average, they anticipate OraSure Technologies' share price to reach $15.83 in the next twelve months. This suggests a possible upside of 66.1% from the stock's current price.
View analysts' price targets for OraSure Technologies or view top-rated stocks among Wall Street analysts.

Who are OraSure Technologies' key executives?

OraSure Technologies' management team includes the following people:

• Stephen S. Tang, President, Chief Executive Officer & Director
• James Ted Rauth, Senior Vice President-Operations
• Scott K. Gleason, CFO, SVP-Investor Relations & Communications
• Jack E. Jerrett, Secretary, Chief Compliance Officer & Senior VP
• Kathleen G. Weber, EVP-Business Unit Leader & Molecular Solutions

What is Stephen Tang's approval rating as OraSure Technologies' CEO?

2 employees have rated OraSure Technologies CEO Stephen Tang on Glassdoor.com. Stephen Tang has an approval rating of 100% among OraSure Technologies' employees. This puts Stephen Tang in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of OraSure Technologies' key competitors?

Some companies that are related to OraSure Technologies include Align Technology (ALGN), West Pharmaceutical Services (WST), Cooper Companies (COO), DENTSPLY SIRONA (XRAY), Quidel (QDEL), ICU Medical (ICUI), STAAR Surgical (STAA), Neogen (NEOG), Merit Medical Systems (MMSI), Haemonetics (HAE), Atrion (ATRI), Cerus (CERS), Meridian Bioscience (VIVO), Anika Therapeutics (ANIK) and Antares Pharma (ATRS).
View all of OSUR's competitors.

What other stocks do shareholders of OraSure Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OraSure Technologies investors own include Merit Medical Systems (MMSI), Citigroup (C), Energy Transfer (ET), XOMA (XOMA), Overstock.com (OSTK), Ford Motor (F), Pfizer (PFE), Abbott Laboratories (ABT), Advanced Micro Devices (AMD) and Activision Blizzard (ATVI).

What is OraSure Technologies' stock symbol?

OraSure Technologies trades on the NASDAQ under the ticker symbol "OSUR."

Who are OraSure Technologies' major shareholders?

OraSure Technologies' stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (19.06%), Camber Capital Management LP (5.90%), American Capital Management Inc. (5.08%), Dimensional Fund Advisors LP (4.00%), Neuberger Berman Group LLC (2.67%) and Geode Capital Management LLC (1.71%).
View institutional ownership trends for OraSure Technologies.

Which institutional investors are selling OraSure Technologies stock?

OSUR stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Morgan Stanley, Jane Street Group LLC, Invesco Ltd., South Dakota Investment Council, Los Angeles Capital Management LLC, Primecap Management Co. CA, and UBS Group AG.
View insider buying and selling activity for OraSure Technologies or view top insider-selling stocks.

Which institutional investors are buying OraSure Technologies stock?

OSUR stock was bought by a variety of institutional investors in the last quarter, including RTW Investments LP, Camber Capital Management LP, Millennium Management LLC, Marshall Wace LLP, Kornitzer Capital Management Inc. KS, Goldman Sachs Group Inc., Dimensional Fund Advisors LP, and Deutsche Bank AG.
View insider buying and selling activity for OraSure Technologies or or view top insider-buying stocks.

How do I buy shares of OraSure Technologies?

Shares of OSUR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is OraSure Technologies' stock price today?

One share of OSUR stock can currently be purchased for approximately $9.53.

How much money does OraSure Technologies make?

OraSure Technologies has a market capitalization of $686.52 million and generates $171.72 million in revenue each year. The medical instruments supplier earns $-14.92 million in net income (profit) each year or ($0.15) on an earnings per share basis.

How many employees does OraSure Technologies have?

OraSure Technologies employs 570 workers across the globe.

What is OraSure Technologies' official website?

The official website for OraSure Technologies is www.orasure.com.

Where are OraSure Technologies' headquarters?

OraSure Technologies is headquartered at 220 EAST FIRST STREET, BETHLEHEM PA, 18015.

How can I contact OraSure Technologies?

OraSure Technologies' mailing address is 220 EAST FIRST STREET, BETHLEHEM PA, 18015. The medical instruments supplier can be reached via phone at (610) 882-1820, via email at [email protected], or via fax at 610-882-1830.